1 suspended. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SY007 in Patients With Acute Ischemic Stroke SY-007/ Placebo 15mg, SY-007/ Placebo 30mg, SY-007/ Placebo 60mg - Acute Ischemic Stroke | Phase 1 | Suspended | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 36 | 2023-07-01 | 2022-06-27 |
Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Nervous System Diseases (1) · Stroke (1) · Vascular Diseases (1)
Suzhou Yabao Pharmaceutical R&D Co., Ltd. (1)
China (1)